Form 10-K Actinium Pharmaceuticals For: Dec 31
![SEC EDGAR](../../../Content/images/providers/SC.png)
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
NASDAQ:AMEX Investor Relations:
ir.actiniumpharma.com
Company Research
Source: SEC EDGAR
![SEC EDGAR](../../../Content/images/providers/SC.png)
Impact Snapshot
Event Time:
ATNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATNM alerts
High impacting Actinium Pharmaceuticals, Inc. (Delaware) news events
Weekly update
A roundup of the hottest topics
ATNM
News
- Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions [Yahoo! Finance]Yahoo! Finance
- Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials IncreaseGlobeNewswire
- Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking TherapiesGlobeNewswire
- Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML) [Yahoo! Finance]Yahoo! Finance
ATNM
Earnings
- 8/14/23 - Miss
ATNM
Sec Filings
- 4/26/24 - Form 10-Q
- 3/29/24 - Form S-8
- ATNM's page on the SEC website